4//SEC Filing
ONCOGENEX PHARMACEUTICALS, INC. 4
Accession 0001209191-15-045785
$ACHVCIK 0000949858operating
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:34 AM ET
Size
12.2 KB
Accession
0001209191-15-045785
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Exercise/Conversion
Common Stock
2015-05-20+2,500→ 14,562 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2015-05-20−2,500→ 0 totalFrom: 2015-05-20→ Common Stock (2,500 underlying) - Award
Stock Option (right to buy)
2015-05-21+5,000→ 5,000 totalExercise: $1.89Exp: 2025-05-21→ Common Stock (5,000 underlying) - Award
Restricted Stock Unit (RSU)
2015-05-21+2,500→ 2,500 total→ Common Stock (2,500 underlying)
Footnotes (6)
- [F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
- [F2]RSUs convert into common stock on a one-for-one basis.
- [F3]Each RSU represents a contingent right to receive one share of the issuer's common stock.
- [F4]The RSUs expire 30 days from the date they vest.
- [F5]The options vest 100% on the earlier of May 21, 2016 or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F6]The RSUs vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders, if this date is when the issuer's trading window is closed, it will vest the first day thereafter during which the issuer's trading window is open.
Documents
Issuer
ONCOGENEX PHARMACEUTICALS, INC.
CIK 0000949858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000949858
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 9:34 AM ET
- Size
- 12.2 KB